Instituto de Neurología Cognitiva (INECO)

Marcelo Torcuato de Alvear 1632, C1021 Cdad. Autónoma de Buenos Aires, Argentina

Select an option

I am a doctor

I am a sponsor

Our team

Medical staff

Vladimiro Sinay

Carolina Pardo

Guido Vazquez

Adriana Carra

Gonzalo Gomez Arevalo

Legal and Administrative staff

Investigadora PrincipalPaula Asorey

Open studies

Multiple sclerosis

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) - REMODEL-1 - Novartis Pharmaceuticals

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis - FREVIVA - Sanofi

Cerebral Palsy

Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy - Neurocrine Biosciences

Dyskinesia

Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy - Neurocrine Biosciences

Multiple Sclerosis

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis - FREXALT - Sanofi

About usOur mission Our team Partners FAQs

Medical newsLatest news Studies Interviews Testimonials

ProductsUEPM Onco UEPM Physicians

LinksDownloads

Instituto de Neurología Cognitiva (INECO)

Marcelo Torcuato de Alvear 1632, C1021 Cdad. Autónoma de Buenos Aires, Argentina

Select an option

I am a doctor

I am a sponsor

Our team

Medical staff

Vladimiro Sinay

Carolina Pardo

Guido Vazquez

Adriana Carra

Gonzalo Gomez Arevalo

Legal and Administrative staff

Investigadora PrincipalPaula Asorey

Open studies

Multiple sclerosis

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) - REMODEL-1 - Novartis Pharmaceuticals

Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis - FREVIVA - Sanofi

Cerebral Palsy

Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy - Neurocrine Biosciences

Dyskinesia

Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy - Neurocrine Biosciences

Multiple Sclerosis

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis - FREXALT - Sanofi

About usOur mission Our team Partners FAQs

Medical newsLatest news Studies Interviews Testimonials

ProductsUEPM Onco UEPM Physicians

LinksDownloads